Pathophysiology of Parkinson’s disease and the efficiency of its treatment
Автор: Jalalov Ravshanbek, Salieva Minara, Abdurahimov Abdukhalim, Nugmanov Ozodbek
Журнал: Re-health journal.
Рубрика: Неврология
Статья в выпуске: 2,3 (6), 2020 года.
Бесплатный доступ
Parkinsonism is a secondary neurodegenerative disease characterized by degeneration of dopaminergic neurons, accompanied by motor and non-motor symptoms. Primary neurodegenerative disease Alzheimer’s is a syndrome of mental retardation and memory loss. Parkinson's is one of the most common diseases in the world. It is mainly found in people over 50 years of age. According to modern statistics, about 100 million people are infected with Parkinson's disease. Of these, 40% are in North Africa and the Arab world as a whole, and about 14% are Ashkenazi Jews. This article discusses the pathophysiology of Parkinsonism and its treatment.
Parkinsonism, dopaminergic, degeneration, neurodegenerative, alzheimer's syndrome, pathophysiology, parkinsonizm, dopaminergik, degeneratsiya, neyrodegenerativ, altsgeymer sindromi, patofiziologiya
Короткий адрес: https://sciup.org/14125584
IDR: 14125584 | DOI: 10.24411/2181-0443/2020-10083
Список литературы Pathophysiology of Parkinson’s disease and the efficiency of its treatment
- Connolly BS, Lang AE (23-30 April 2014). "Pharmacological treatment of Parkinson disease: a review". JAMA. 311 (16): 1670-83.
- The non-motor and non-dopaminergic fratures of PD. Parkinson's Disease: Non-Motor and Non-Dopaminergic Features. Olanow, C. Warren., Stocchi, Fabrizio., Lang, Anthony E. Wiley-Blackwell. 2011. 978-1405191852.
- ISBN: 978-1-4051-9185-2
- The National Collaborating Centre for Chronic Conditions, ed. (2006). "Symptomatic pharmacological therapy in Parkinson's disease". Parkinson's Disease. London: Royal College of Physicians. pp. 59-100. 978-1-86016-283-1. Archived from the original on 24 September 2010.
- ISBN: 978-1-86016-283-1
- Zhang J, Tan LC (2016). "Revisiting the Medical Management of Parkinson's Disease: Levodopa versus Dopamine Agonist". Current Neuropharmacology. 14 (4): 356-63. PMC 4876591.
- Pedrosa DJ, Timmermann L (2013). "Review: management of Parkinson's disease". Neuropsychiatric Disease and Treatment. 9: 321-40. PMC 3592512. PMID 23487540. RE-HEALTH JOURNAL 2.3-2020 55.
